Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma

Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma

Mucosal melanoma can be driven by various driver mutations in genes such as <i>NRAS</i>, <i>KIT</i>, or <i>KRAS</i>. However, some cases present with only weak drivers, or lacking known oncogenic drivers, suggesting immunotherapy over targeted therapy. While resis...

Full description

Bibliographic Details
Main Authors: Sandra N. Freiberger, Patrick Turko, Martin Hüllner, Reinhard Dummer, Grégoire B. Morand, Mitchell P. Levesque, David Holzmann, Niels J. Rupp
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
mucosal melanoma
sinonasal cancer
oncogenic driver
immunotherapy
tumor heterogeneity
disease monitoring
Online Access:https://www.mdpi.com/2072-6694/13/11/2725

Internet

https://www.mdpi.com/2072-6694/13/11/2725

Similar Items